FDA’s Center for Drug Evaluation and Research (CDER) announced the launch of the CDER Center for Clinical Trial Innovation (C3TI). C3TI’s mission is to promote CDER clinical trial innovation activities through enhanced communication and collaboration, both internally within CDER and externally.Continue reading
Author Archive: AZBio
The University of Arizona Incubator Network Collaborates with Oro Valley to Sponsor Startup Success
TUCSON, Ariz. — The University of Arizona Center for Innovation (UACI), which serves as the science and technology startup incubator network of Tech Parks Arizona, is pleased to announce the open call for the UACI Sponsored Launch Fueled by the Oro Valley Chamber of Commerce and Town of Oro Valley competition. The winning startup will receive sponsored entry into UACI at Oro Valley, the prestigious bioscience-focused incubator, along with resources , specialized facilities, services and expert guidance to grow their business. Continue reading
GammaTile® Marks Milestone: 100th Patient Enrolled in Groundbreaking ROADS Phase 3 Clinical Trial for Newly Diagnosed Metastatic Brain Tumors
Randomized Controlled Trial Targets Residual Cancer Cells during Brain Surgery with Implant Delivering Radiation, Aiming to Advance Local Control Continue reading
Theriome Unveils Advanced Personalized Health Testing Platform, Shaping the Future of Precision Medicine
In a significant leap forward for precision medicine, Theriome is excited to announce the launch of its state-of-the-art personalized health testing platform. This breakthrough is set to redefine the parameters of healthcare, delivering highly individualized health insights with unprecedented accuracy.Continue reading
TGen’s 2024 John S. McCain Leadership Award — Kevin Conroy of Exact Sciences
Kevin Conroy, Chairman and CEO of Exact Sciences was presented with the John S. McCain Leadership Award at the 20th annual TGen Founders Dinner. The annual award recognizes individuals or organizations whose leadership and dedication have made a significant impact in the fight against cancer and helping patients worldwide.Continue reading
Ivy Brain Tumor Center Announces Promising Results of Phase 0/1 Glioblastoma Study at the American Association for Cancer Research Annual Meeting
Oral presentation features interim data on the pharmacodynamics and pharmacokinetics of ATM inhibitor in combination with radiation in newly diagnosed glioblastomaContinue reading
TGen Study Reveals Genetic Drivers of Common Liver Disease
Meta-analysis points to potential new therapeutic pathwaysContinue reading
Understanding How Changes to the Bayh-Dole Act Could Stifle American Innovation
On Thursday, April 4, 2024, the Bayh-Dole Coalition and the Licensing Executives Society hosted a webinar on these two threats and their consequences for U.S. taxpayers, businesses, and the economy at-large.Continue reading
Six Arizona startups driving biosciences forward in 2024
Arizona-based bioscience companies developing blood tests to diagnose cancer and other diseases more quickly and accurately, AI tools to automate lab work, and an alternative way to treat itchiness in dogs have been selected for the 2024 Flinn Foundation Bioscience Entrepreneurship Program. Four of the six early-stage companies representing the 11th cohort of the program are based in Tucson and two are based in the Phoenix area, including one in Carefree.Continue reading
Abbott Receives FDA Clearance for Whole Blood Rapid Test to Help with Assessment of Concussion at the Patient’s Bedside
- The test, run on Abbott’s portable i-STAT® Alinity® instrument, uses whole blood to help evaluate patients with a suspected mild traumatic brain injury (mTBI), or concussion
- The test produces lab-quality results in 15 minutes
- Clinicians are now able to get a result at the patient’s bedside, making the test accessible at urgent care clinics and other healthcare settings outside the hospital emergency room
- The test can be used to help evaluate patients up to 24 hours after injury